Article Details
Retrieved on: 2025-02-07 16:32:16
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses a new nasal COVID-19 vaccine developed with Washington University technology, approved for U.S. trials by the FDA. The vaccine utilizes an attenuated adenovirus and offers easier administration and potentially stronger immunity.
Article found on: www.firstalert4.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here